|
FNIP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.67769966994558E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.824700E-04 |
| Normal-vs-Stage2 |
1.240550E-03 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.322560E-03 |
| Stage1-vs-Stage2 |
3.104600E-01 |
| Stage1-vs-Stage3 |
5.23120002871025E-09 |
| Stage1-vs-Stage4 |
9.407600E-02 |
| Stage2-vs-Stage3 |
2.107800E-02 |
| Stage2-vs-Stage4 |
4.158600E-01 |
| Stage3-vs-Stage4 |
4.919000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.24649998393068E-10 |
| Normal-vs-AfricanAmerican |
2.860300E-03 |
| Normal-vs-Asian |
7.834600E-01 |
| Caucasian-vs-AfricanAmerican |
7.564600E-01 |
| Caucasian-vs-Asian |
3.271400E-01 |
| AfricanAmerican-vs-Asian |
3.667400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.48839854172434E-11 |
| Normal-vs-Female |
6.417300E-04 |
| Male-vs-Female |
1.349980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.14059999912453E-08 |
| Normal-vs-Age(41-60Yrs) |
4.243500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.67843516862831E-12 |
| Normal-vs-Age(81-100Yrs) |
3.28109999947479E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.269780E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.291600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.643800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.821600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.001800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.136400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.448600E-01 |
| Normal-vs-Grade 2 |
3.16479999984409E-07 |
| Normal-vs-Grade 3 |
1.93676999999948E-05 |
| Normal-vs-Grade 4 |
1.62947433324234E-12 |
| Grade 1-vs-Grade 2 |
1.664790E-01 |
| Grade 1-vs-Grade 3 |
1.331620E-01 |
| Grade 1-vs-Grade 4 |
4.442700E-04 |
| Grade 2-vs-Grade 3 |
4.757200E-01 |
| Grade 2-vs-Grade 4 |
1.5007999999983E-05 |
| Grade 3-vs-Grade 4 |
5.500100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.11839999999519E-05 |
| Normal-vs-ccB subtype |
1.90410000000529E-06 |
| ccA subtype-vs-ccB subtype |
9.679700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61529999997967E-06 |
| Normal-vs-N1 |
2.90449999607034E-08 |
| N0-vs-N1 |
1.501640E-02 |
|
|
